Summary of Study ST000601

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000438. The data can be accessed directly via it's Project DOI: 10.21228/M8FC7C This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Show all samples  |  Perform analysis on untargeted data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST000601
Study TitleUntargeted LC-MS metabolomics analysis of human COPD plasma, HILIC & C18
Study SummaryIdentify perturbed metabolites and pathways in human plasma collected from 131 COPD subjects. Subjects were either current or former smokers with various COPD phenotypes including emphysema, and exacerbations.
Institute
University of Colorado Denver
Department Anschutz Medical Campus, Pharmaceutical Sciences
Last NameReisdorph
First NameNichole
Address12850 East Montview Blvd, Aurora, CO 80045
EmailNichole.Reisdorph@ucdenver.edu
Phone303-724-9243
Submit Date2017-04-27
Total Subjects131
Num Males56
Num Females75
Raw Data AvailableYes
Raw Data File Type(s)d
Analysis Type DetailLC-MS
Release Date2018-10-10
Release Version1
Nichole Reisdorph Nichole Reisdorph
https://dx.doi.org/10.21228/M8FC7C
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Project:

Project ID:PR000438
Project DOI:doi: 10.21228/M8FC7C
Project Title:Chronic Obstructive Pulmonary Disease Human Plasma Metabolomics
Project Type:Untargeted LC-MS Metabolomics
Project Summary:COPD is a very heterogeneous disease comprising multiple phenotypes. Plasma from 131 human subjects was collected as part of the NIH-sponsored COPDGene cohort and analyzed using untargeted LC-MS (C18+) and (HILIC+) metabolomics. The goal was to identify perturbed compounds and pathways associated with COPD.
Institute:University of Colorado Denver
Department:Pharmaceutical Sciences, Anschutz Medical Campus
Last Name:Reisdorph
First Name:Nichole
Address:12850 East Montview Blvd, Aurora, CO 80045
Email:Nichole.Reisdorph@ucdenver.edu
Phone:303-724-9243
Funding Source:NIH P20
  logo